相关实验视频
Updated: May 24, 2025

08:18
Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
16.7K
癌症和衰老中的代谢重编程
Yuzhu Zhang1, Jiaxi Tang1, Can Jiang1
1Department of Pathology Xiangya Hospital School of Basic Medical Sciences Central South University Changsha China.
MedComm
|March 6, 2025
概括
衰老和癌症通过营养感知和代谢变化共享联系. 这篇评论探讨了细胞衰老如何影响瘤生长,讨论了干预措施,并建议饮食习惯,以打击衰老和潜在的癌症.
科学领域:
- 老年病学和瘤学
- 在衰老和癌症中的代谢调节
背景情况:
- 全球癌症发病率正在上升,与人口老龄化有关.
- 癌症发病率和死亡率随着年龄的增长而增加.
- 衰老中的营养感知失调与瘤代谢重编程类似,但这种关系尚不清楚.
研究的目的:
- 综合分析衰老与瘤代谢重编程之间的关系.
- 揭示关键衰老因素对瘤发生的影响.
- 总结针对癌症治疗中的营养感知和衰老的干预措施.
主要方法:
- 文献审查和现有研究的分析.
- 检查细胞衰老的关键因素及其在癌症中的作用.
- 针对衰老向癌症疗法的当前纳米输送策略的摘要.
主要成果:
- 衰老显著影响癌症发病率和死亡率.
- 细胞衰老和代谢重编程在癌症发育中相互关联.
- 营养感知通路对于衰老和癌症都至关重要.
结论:
- 了解衰老与新陈代谢之间的联系为癌症治疗提供了新的途径.
- 准衰老和营养感应通路显示出治疗潜力.
- 饮食习惯可以影响衰老,并可能影响癌症风险.
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K

